Hantavirus has recently become the unexpected star of a renewed flurry of online conspiracy theories, harking back to the chaotic days of the COVID-19 pandemic. Imagine the scene: an outbreak of hantavirus on an Atlantic cruise ship, and suddenly, the internet explodes with claims that it’s all a grand deception. People are propagating false narratives, asserting that an old research project by Moderna focusing on hantavirus proves the virus itself is a “hoax.” Their argument? That this perceived “hoax” was meticulously crafted to pave the way for a massive vaccination campaign, mirroring what they believe happened with COVID-19. However, the reality is far from this sensationalized storyline. In fact, a leading professor from Moderna’s partner university in South Korea clarified that this research initiative wasn’t some covert operation. Instead, its purpose was to tackle a “long-neglected pathogen”—hantavirus—which has been quietly infecting people since its first documented appearance in the 1950s. While acknowledging its potential deadliness, multiple health experts have been quick to reassure the public: a global pandemic from hantavirus is highly improbable, a stark contrast to the widespread devastation of COVID-19.
The very notion of a “hanta ‘virus’ hoax” quickly gained traction on social media, especially on platforms like X (formerly Twitter). One particularly viral Korean-language post, shared in early May 2026, dramatically declared, “Exposing the hanta ‘virus’ hoax!!” It sensationally claimed that Moderna’s decision to begin developing an mRNA vaccine for hantavirus in 2024 was the “exact same playbook” as seen during the COVID-19 pandemic. According to this narrative, the strategy was clear: “Scaring the public, stoking anxiety and ultimately pushing a new mRNA vaccine — a classic Deep State tactic.” The post even referenced press releases detailing the collaboration between Moderna, the well-known COVID-19 vaccine manufacturer, and Korea University’s College of Medicine for an mRNA-based hantavirus jab. This pattern of suspicion wasn’t confined to a single language or region; similar false claims spread like wildfire across Chinese, Dutch, and English-speaking communities. Some voices even went as far as to state that hantavirus “does not exist,” or that the deadly outbreak on the MV Hondius cruise ship was “pre-planned.” These claims echo the very same baseless accusations that plagued the early days of the coronavirus pandemic, where opponents of COVID-19 vaccines argued that the entire pandemic was concocted to enrich vaccine manufacturers like Moderna or to advance a sinister “depopulation” agenda. As with previous waves of misinformation surrounding COVID-19, these circulating claims about hantavirus are demonstrably inaccurate and serve only to sow confusion and distrust.
Behind the sensational headlines and conspiracy theories lies the nuanced reality of scientific research and public health. Kim Woo-joo, the chair professor at Korea University’s College of Medicine, a key partner in Moderna’s hantavirus research, expressed frustration at the misrepresentation of their work. He emphasized that their collaboration with Moderna was specifically aimed at addressing a “long-neglected pathogen.” The professor pointed out that while hantavirus cases might be relatively uncommon, some strains carry a high fatality rate, making it a legitimate “major public health concern,” as also stated by the World Health Organization (WHO). Professor Kim lamented the transient nature of public attention, noting, “People pay attention when a high-profile death occurs, and then ask why there is no vaccine, but interest quickly fades.” This fleeting interest often leaves vital scientific research unfunded and underdeveloped. Moderna, independently, affirmed to AFP that their partnership with Korea University is an integral part of the company’s broader efforts to “develop countermeasures against emerging infectious diseases.” It’s also worth noting that this research initiative was not a secret, as some conspiratorial posts suggested. On the contrary, it was widely covered by local media at the time, openly contradicting any claims of secrecy. Currently, there are no universally approved vaccines or specific treatments available for hantavirus. Although inactivated hantavirus vaccines, containing weakened or deactivated forms of the pathogen, have been developed in countries like South Korea and China, experts like Kim Won-keun, an associate professor of microbiology at Hallym University, stress that these older vaccines “need to be updated to match strains that are circulating today.” This ongoing research is not about creating a new global crisis, but rather about preparing for and managing existing health threats.
A crucial distinction to make, and one that often gets lost in the noise of online misinformation, is the vastly different pandemic risk posed by hantavirus compared to COVID-19. Christian Lindmeier, a spokesperson for the WHO, clearly articulated this difference, stating that the risk hantavirus poses to the general population is “absolutely low.” Unlike COVID-19, which claimed millions of lives globally, hantavirus, while certainly a “dangerous virus,” primarily poses a threat “only to the person who is really infected.” Professor Kim, the microbiology expert, further elaborated on this, explaining that due to hantavirus’s limited mode of transmission, the likelihood of it causing a global pandemic is exceedingly small. The common route of transmission for the strains that infect humans is through inhaling aerosols contaminated by the saliva, droppings, or urine of infected rodents. This makes human-to-human transmission rare. However, the recent outbreak on the cruise ship did highlight a specific strain: the Andes virus, which is the only hantavirus strain known to be transmitted directly between humans. Out of the ten cases reported on the ship, including three fatalities, eight were confirmed to be Andes virus infections. All known cases in this specific outbreak involved individuals aboard the Dutch-flagged vessel traveling from Argentina to Cape Verde. Interestingly, suspicions arose that the first person to die and his wife, who passed away two weeks later, might have contracted the virus in Ushuaia, Argentina, before boarding the cruise. However, provincial officials in Argentina have denied this hypothesis, with local scientists suggesting it’s more probable that the infections occurred in another region. This detailed understanding of transmission routes and specific strains underscores why health experts confidently state the low pandemic risk of hantavirus, contrasting sharply with the highly contagious nature of COVID-19.
Delving deeper into the nature of hantavirus reveals that it is far from a newly discovered threat. Unlike COVID-19, which emerged as a previously unknown virus in late 2019, hantavirus has a long and documented history. It’s not some novel pathogen fabricated for a “hoax.” Hantaviruses are broadly categorized into two groups: the “old world” viruses found in Europe, Asia, and Africa, and the “new world” viruses prevalent in North, Central, and South America. This geographical distribution and classification are the result of extensive scientific study. Two significant outbreaks, historically, played a pivotal role in the discovery and differentiation of these distinct groups. The first major event occurred during the 1950-53 Korean War, where over 3,000 United Nations troops fell ill. This outbreak was so significant that it led to the virus being named after the Hantan River in South Korea, solidifying its place in medical history. The second major outbreak unfolded in the southwestern United States in 1993, where 18 patients were confirmed to have the disease. These historical events demonstrate that hantavirus is a well-established pathogen. In fact, its significance led to it becoming a nationally notifiable disease in the United States in 1995, meaning health authorities must continuously monitor and report cases. Similarly, in South Korea, hantavirus became a reportable disease requiring continuous surveillance as early as 1976, according to the Korea Disease Control and Prevention Agency. These historical facts and established surveillance systems clearly debunk any notion that hantavirus is a fabricated entity. AFP, a reputable news agency, has repeatedly engaged in debuking other false claims about hantavirus, further highlighting the ongoing struggle against misinformation surrounding this long-known pathogen.
In essence, the recent hantavirus outbreak on a cruise ship has inadvertently pulled a long-understood, albeit often neglected, virus into the spotlight of online conspiracy theories. These theories, unfortunately, feed on the residual anxieties and distrust stemming from the COVID-19 pandemic, repackaging old misinformation tropes about “Deep State” plots and fabricated diseases. The reality, as explained by scientific experts and historical records, paints a completely different picture. Moderna’s research, far from being a conspiratorial ploy, is a legitimate effort to address a real public health concern – a pathogen that has been infecting humans for decades and continues to pose a risk, particularly in specific regions and under certain conditions. The virus’s low pandemic risk, its distinct transmission routes, and its extensive historical documentation all stand in stark contrast to the sensationalized claims. This situation serves as a powerful reminder of how easily misinformation can take root, especially when it taps into existing fears and doubts. It underscores the critical importance of relying on credible sources, scientific evidence, and expert consensus to navigate complex health topics, rather than falling prey to unsupported allegations that undermine public trust and distract from genuine efforts to protect human health.